Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

oncology vaccines

Vaccines

Vaccines Today—April 30, 2026

This weekly update in Vaccines Research highlights recent regulatory actions,…

Vaccines

Vaccines Today—April 24, 2026

This weekly update in vaccines and immunotherapy covers recent developments…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
LucidWargames
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Oncology Today—June 8, 2026
Hematology Today—June 8, 2026
Nurix Roche Bexobrutideg Deal | Lucid Diligence Brief
GNI Group Acquires Ayumi Pharmaceutical | Lucid Diligence Brief
Public Health Today—June 5, 2026

Tags

AgenT-797 AI in drug discovery AlphaFold 3 antibody-drug conjugates Biomarkers Cambridge cluster CDMO capacity CLN3 Batten disease Contrast Management CVI-VZV-001 cylembio Dongkook Pharmaceutical Efpeglenatide FoundationOne CDx Fracture risk functional cure Helicon Helixmith hematopoietic stem cell transplantation HR-Positive HER2-Negative Advanced Breast Cancer Ilumya Ketowhistle meta michael burry Mission Bio mylife Loop Neurotech International Nicotine Regulation Palmitoylethanolamide Pasithea Therapeutics Pie Medical Imaging Post-Acute Infection Syndromes provider MSO Qilu Pharmaceutical QT-019C Relapsed Or Refractory Acute Myeloid Leukemia Robotic microsurgery siRNA Spevigo Sunitinib uMRD Vaccine Market Vascular disease Vincentage Pharma Zorevunersen

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Oncology Today—June 8, 2026
Hematology Today—June 8, 2026
Nurix Roche Bexobrutideg Deal | Lucid Diligence Brief
GNI Group Acquires Ayumi Pharmaceutical | Lucid Diligence Brief
Public Health Today—June 5, 2026

TAGS

AgenT-797 AI in drug discovery AlphaFold 3 antibody-drug conjugates Biomarkers Cambridge cluster CDMO capacity CLN3 Batten disease Contrast Management CVI-VZV-001 cylembio Dongkook Pharmaceutical Efpeglenatide FoundationOne CDx Fracture risk functional cure Helicon Helixmith hematopoietic stem cell transplantation HR-Positive HER2-Negative Advanced Breast Cancer Ilumya Ketowhistle meta michael burry Mission Bio mylife Loop Neurotech International Nicotine Regulation Palmitoylethanolamide Pasithea Therapeutics Pie Medical Imaging Post-Acute Infection Syndromes provider MSO Qilu Pharmaceutical QT-019C Relapsed Or Refractory Acute Myeloid Leukemia Robotic microsurgery siRNA Spevigo Sunitinib uMRD Vaccine Market Vascular disease Vincentage Pharma Zorevunersen

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy